Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Receivables - Other: 2014-2025

Historic Receivables - Other for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to $2.0 million.

  • AC Immune's Receivables - Other rose 97.17% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 97.17%. This contributed to the annual value of $2.0 million for FY2025, which is N/A change from last year.
  • As of FY2025, AC Immune's Receivables - Other stood at $2.0 million, which was up 156,823.87% from $1,260 recorded in FY2024.
  • In the past 5 years, AC Immune's Receivables - Other ranged from a high of $2.0 million in FY2025 and a low of $701.21 during FY2023.
  • For the 3-year period, AC Immune's Receivables - Other averaged around $659,860, with its median value being $1,260 (2024).
  • As far as peak fluctuations go, AC Immune's Receivables - Other slumped by 99.83% in 2023, and later spiked by 79.72% in 2024.
  • AC Immune's Receivables - Other (Yearly) stood at $468,381 in 2021, then fell by 13.13% to $406,905 in 2022, then tumbled by 99.83% to $701.21 in 2023, then soared by 79.72% to $1,260 in 2024, then reached $2.0 million in 2025.